Welcome to LookChem.com Sign In|Join Free

CAS

  • or

110567-21-0

Post Buying Request

110567-21-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

110567-21-0 Usage

Uses

(1S,2R)-2-((Benzyloxy)methyl)cyclopent-3-enol is an intermediate in the synthesis of Entecavir (E558900), an oral antiviral drug used in the treatment of hepatitis B infection.

Check Digit Verification of cas no

The CAS Registry Mumber 110567-21-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,0,5,6 and 7 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 110567-21:
(8*1)+(7*1)+(6*0)+(5*5)+(4*6)+(3*7)+(2*2)+(1*1)=90
90 % 10 = 0
So 110567-21-0 is a valid CAS Registry Number.
InChI:InChI=1/C13H16O2/c14-13-8-4-7-12(13)10-15-9-11-5-2-1-3-6-11/h1-7,12-14H,8-10H2/t12-,13+/m1/s1

110567-21-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name (1S,2R)-2-(Benzyloxymethyl)-1-hydroxy-3-cyclopentene

1.2 Other means of identification

Product number -
Other names (1S,2R)-2-(phenylmethoxymethyl)cyclopent-3-en-1-ol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:110567-21-0 SDS

110567-21-0Relevant articles and documents

PCSK9 INHIBITORS AND METHODS OF USE THEREOF

-

Page/Page column 146-147, (2020/07/31)

The invention relates to a novel inhibitor pharmacophore of PCSK9 and heteroaryl compounds that bind the PCSK9 protein.

STING MODULATOR COMPOUNDS, AND METHODS OF MAKING AND USING

-

, (2019/05/30)

The present disclosure provides STING modulators/agonists, and methods of synthesis and methods for using for the prophylaxis or treatment of cancer and other STING-related diseases. The present disclosure relates to a compound represented by the Formula (I): wherein each symbol is as defined in the description, or a pharmaceutically acceptable salt thereof.

The synthesis of possible transition state analogue inhibitors of thymidine phosphorylase

Evans, Gary B.,Gainsford, Graeme J.,Schramm, Vern L.,Tyler, Peter C.

, p. 406 - 409 (2015/04/27)

The synthetically challenging SN2 transition state mimic for thymidine phosphorylase, along with its phosphonate analogue, were synthesised via a modified Corey-Link reaction in good overall yields and ensuring the correct stereochemical outcome.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 110567-21-0